O4 Development and validation of dimethylarginines (DAS) as a novel biomarker to identify pre-ACLF and predict outcomes following acute decompensation of cirrhosis in two prospective multicentre European cohorts
Kohilan Gananandan, Peter Holland‐Fischer, Karen Louise Thomsen, Konstantin Kazankov et autres
gb, dk, au, es, it, be, de (code pays fourni par la source)